Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Janusz Gumprecht

ResearcherPublications, citations & collaboration network

Janusz Gumprecht is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 307 works, 5,034 citations, an h-index of 34 and an i10-index of 79.

307
Works
5,034
Citations
34
h-index
79
i10-index

How has Janusz Gumprecht's publication output changed over time?

ScholarIQpublication output · 2007–2026

Output grew0% over the shown period — from 1 works in 2007 to 1 in 2026.

1
1
3
3
2
1
200720172019202120222026

What are the most-cited papers on Janusz Gumprecht?

ScholarIQmost cited works
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Helena W. Rodbard, Julio Rosenstock, Luís Henrique Santos Canani, Chaicharn Deerochanawong, Janusz Gumprecht, Søren Lindberg, Ildiko Lingvay, ANETTE L. SØNDERGAARD, Marianne Bach Treppendahl, Eduard Montanya, PIONEER 2 Investigators, Pablo Jordão Alcântara Cruz, Luis De Loredo, Cecilia Luquez, Maria Alejandra Moisello, Gustavo Akerman Augusto, Marise Lazaretti Castro, Luís Henrique Santos Canani, Branko Akrap, Tomislav Bulum, Dario Rahelić, Ivana Sunic-Grcic, Srecko Tusek, Iakovos Avramidis, Marian Benroubi, Triantafyllos Didangelos, Gerasimos Karousos, Emmanouil Pagkalos, Christos Sampanis, Maria Somali, Zsolt Domboróczki, Péter Faludi, Zsolt Gaál, Piroska Kis-Gombos, Győző Kocsis, Zoltán Márton, Zsolt Sudár, Silvio Buscemi, Alberto Di Carlo, Francesco Dotta, Alessandra Gambineri, Davide Lauro, Marianna Maranghi, Małgorzata Arciszewska, Janusz Gumprecht, Krystyna Matuszewska, Ewa Skokowska, Teresa Stasinska, Svetlana Feofanova, Е. О. Филиппова, G. R. Galstyan, Leylya Gaysina, М. А. Куницына, Л. А. Суплотова, Slobodan Antić, Aleksandar Djukić, Milena Mitrović, Milica Pešić, Edita Stokić, Esteban Jódar, Encarna Martínez, Pedro Mezquita Raya, Eduard Montanya, Cristobal Morales Portillo, Mercè Pérez Vera, Margarita Fernández, Patricia San José, Manel Terns Riera, Apussanee Boonyavarakul, Chaicharn Deerochanawong, Apiradee Sriwijitkamol, Dilawar Ajani, Eddie Armas, Kim Barbel-Johnson, Darlene Bartilucci, Gholamreza Bonabi, Robert S. Busch, David Butuk, Kevin D. Cannon, Craig Chase, Louis Chaykin, Vasundhara Cheekati, Thomas R. A. Davis, Belkis Delgado, Neil Farris, Mark Graves, Chi Ha, Linda Harper, Sharon J. Herring, Mitzie Hewitt, Daniel S. Hsia, Richard A. Jackson, Michael Jardula, Mark Joyce, Mario Juarez, Anoop Kapoor, Dennis G. Karounos, David Kayne, Audrey Lacour, Gilbert Ledesma
Diabetes Care. 2019455 CitationsOPEN ACCESS
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund, Jan W. Eriksson, Simon Heller, Ole Hels, Richard E. Pratley, Thozhukat Sathyapalan, Cyrus Desouza, R.N. Abramof, Diana N Alpenidze, S Aronoff, K. Astamirova, B Barker, Gary Bedel, Lidia Belousova, Mark D. Benson, Isaac Beshay, William Biggs, Kenneth Blaze, Paweł Bogdański, Robert S. Busch, Sushela Chaidarun, Siddharthan Chandran, Alex R. Chang, S Chilka, Alan S. Cleland, Lisa Connery, George Mitchell Cornett, Bruno Delgado, Cyrus Desouza, Thomas Donner, Ken Eliasson, Jan W. Eriksson, Steven Folkerth, Kristy Forshaw, Hans Frandsen, Elena Frolova, Winston Gandy, G Gatipon, Albina Golovach, L. Gonzalez-Orozco, Janusz Gumprecht, Élie Haddad, Troels Krarup Hansen, Thomas C. Hart, Syed Shahzad Hasan, Brent Hella, Simon Heller, Margareta Hellgren, Mark I. Hewitt, S Hietaniemi, Marc‐Phillip Hitz, P Houser, Raphael E. Huntley, R. A. JACKSON, Poul Erik Jakobsen, Anuj Pal Kapoor, L. Kargina, Elena Kazakova, Khalid Khan, E. Klein, H Knoble, N Krasnopeeva, Andre Krzeminski, М. А. Куницына, J Lawhead, Klaus Levin, Philip Levin, Lorena Lewy-Alterbaum, Stina Lindmark, Robert S. Lindsay, Alain Luts, Tatyana Lysenko, Sten Madsbad, Tyler Maxwell, Caroline Mbogua, JA McKnight, Kaj Metsärinne, Т. А. Милованова, Emily Morawski, Ofri Mosenzon, Dan Nabriski, Hai Quy Tram Nguyen, Philip Nicol, Sanna Nieminen, Anita Schwab Nikkola, Paul Norwood, Peter H. O’Donnell, A. Ola Odugbesan, Jeremy C. Parker, Y. Pergaeva, А. Б. Песков, S. Plevin, Joe Pouzar, Richard E. Pratley, Josh Reed, Peter Rossing, Thozhukat Sathyapalan, M. Sergeeva-Kondrachenko
The Lancet Diabetes & Endocrinology. 2019345 CitationsOPEN ACCESS
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes
Wendy Lane, Timothy S. Bailey, Gregg Gerety, Janusz Gumprecht, Athena Philis‐Tsimikas, Charlotte T. Hansen, Thor Schütt Svane Nielsen, Mark Warren, Group Information, The SWITCH 1
JAMA. 2017207 Citations
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Andreas L. Birkenfeld, Janet B. McGill, Sylvia E. Rosas, Amer Joseph, Martin Gebel, Luke Roberts, Markus F. Scheerer, George L. Bakris, Rajiv Agarwal, on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Augusto Vallejos, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Richard J. MacIsaac, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon D. Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Peter G. Colman, David Colquhoun, Chris Ellis, Kim Joshua, Eugenia Pedagogos, Paul Regal, Duncan J. Topliss, James Vandeleur, Johan Verjans, Gary Wittert, Katie-Jane Wynne, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer, Bernhard Paulweber, Rudolf Prager, Wolfgang Preiß, Friedrich C. Prischl, G. Schernthaner, Harald Sourij, Martin Wiesholzer, Heinz Drexel, Rainer Oberbauer, Hans‐Robert Schönherr, Peter Doubel, W. Engelen, Pieter Gillard, Jean‐Michel Hougardy, Jean-Marie Krzesinski, Bart Maes, Marijn M. Speeckaert, Koen Stas, Luc Van Gaal, Hilde Vanbelleghem, Francis Duyck, André Scheen, Daniela Antunes, Roberto Botelho, Cláudia Brito, Luís Henrique Santos Canani, Maria Eugênia Fernandes Canziani, Maria Cerqueira, Rogério de Paula, Freddy G. Eliaschewitz, Carlos Eduardo Poli‐de‐Figueiredo, Adriana Costa e Forti, Miguel Nasser Hissa, Maurilo Leite, Emerson de Lima, Irene L. Noronha, Bruno Paolino
Diabetes Care. 2022206 CitationsOPEN ACCESS
Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
Agata Winiarska, Monika Knysak, Katarzyna Nabrdalik, Janusz Gumprecht, Tomasz Stompór
International Journal of Molecular Sciences. 2021192 CitationsOPEN ACCESS

Related on ScholarIQ

Medical University of Silesia
Institution
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Paper
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Paper
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes
Paper
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Paper
Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
Paper
470M+ articles · free account